Correlation Between CERo Therapeutics and Septerna, Common

Can any of the company-specific risk be diversified away by investing in both CERo Therapeutics and Septerna, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CERo Therapeutics and Septerna, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CERo Therapeutics Holdings and Septerna, Common Stock, you can compare the effects of market volatilities on CERo Therapeutics and Septerna, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CERo Therapeutics with a short position of Septerna, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of CERo Therapeutics and Septerna, Common.

Diversification Opportunities for CERo Therapeutics and Septerna, Common

0.0

Correlation Coefficient

CERo Therapeutics  Septerna, Common

Pay attention - limited upside

The 3 months correlation between CERo and Septerna, is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding CERo Therapeutics Holdings and Septerna, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Septerna, Common Stock and CERo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CERo Therapeutics Holdings are associated (or correlated) with Septerna, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Septerna, Common Stock has no effect on the direction of CERo Therapeutics i.e., CERo Therapeutics and Septerna, Common go up and down completely randomly.

Pair Corralation between CERo Therapeutics and Septerna, Common

Assuming the 90 days horizon CERo Therapeutics Holdings is expected to under-perform the Septerna, Common. In addition to that, CERo Therapeutics is 6.24 times more volatile than Septerna, Common Stock. It trades about -0.02 of its total potential returns per unit of risk. Septerna, Common Stock is currently generating about 0.07 per unit of volatility. If you would invest  2,325  in Septerna, Common Stock on September 24, 2024 and sell it today you would earn a total of  103.00  from holding Septerna, Common Stock or generate 4.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CERo Therapeutics Holdings  vs.  Septerna, Common Stock

CERo Therapeutics

Risk-Adjusted Performance

11 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Septerna, Common Stock

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Septerna, Common Stock are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Septerna, Common displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CERo Therapeutics and Septerna, Common

The main advantage of trading using opposite CERo Therapeutics and Septerna, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CERo Therapeutics position performs unexpectedly, Septerna, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Septerna, Common will offset losses from the drop in Septerna, Common's long position.

The idea behind CERo Therapeutics Holdings and Septerna, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.